What is Outcomes4me?
Outcomes4me operates at the intersection of artificial intelligence, machine learning, and oncology, providing a free digital platform designed to empower cancer patients. By enabling secure input of health data, the platform delivers personalized, evidence-based treatment guidance that aligns with physician reviews and regulatory standards. It also offers information on relevant clinical trials and genetic testing. Notably, Outcomes4me is the first digital platform to integrate with the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, bridging authoritative medical knowledge with accessible technology to enhance transparency and informed decision-making in cancer care.
How much funding has Outcomes4me raised?
Outcomes4me has raised a total of $37.8M across 4 funding rounds:
Other Financing Round
$4.7M
Debt
$149K
Series A
$12M
Other Financing Round
$21M
Other Financing Round (2020): $4.7M with participation from Merstal, Asset Management Ventures, and Sierra Ventures
Debt (2021): $149K led by PPP
Series A (2021): $12M supported by asset management ventures, Sierra Ventures, Northpond Ventures, Merstal, and IRA Capital
Other Financing Round (2025): $21M featuring Sierra Ventures, Silica Investments, and Northpond Ventures
Key Investors in Outcomes4me
Asset Management Ventures
Asset Management Ventures is a venture capital firm with a long-standing history of partnering with entrepreneurs to build technology-based companies. They focus on long-term investments and have evolved into a family office managing Johnson family investments.
Sierra Ventures
Sierra Ventures is a Silicon Valley-based venture capital firm that invests in early-stage technology startups, particularly in enterprise software, infrastructure, data/AI, and frontier tech, supporting companies from product-market fit through scaleup.
Northpond Ventures
Northpond Ventures is dedicated to advancing science and technology to create significant impacts on humanity, focusing on breakthrough innovations and entrepreneurial ventures with the aim of driving meaningful change.
What's next for Outcomes4me?
The recent major strategic investment signals a new phase of growth and development for Outcomes4me. This capital infusion is expected to accelerate the company's mission to improve access to high-quality cancer care by further enhancing its AI capabilities and expanding its platform's reach. Future initiatives will likely focus on deepening its integration with healthcare systems and broadening its support for patients navigating complex treatment journeys, solidifying its position as a leader in digital oncology solutions.
See full Outcomes4me company page
